Iteos Therapeutics Inc
NASDAQ:ITOS
Cash Flow Statement
Cash Flow Statement
Iteos Therapeutics Inc
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||
| Net Income |
(31)
|
(41)
|
(38)
|
(46)
|
(66)
|
15
|
215
|
298
|
330
|
261
|
97
|
12
|
(28)
|
(62)
|
(113)
|
(135)
|
(108)
|
(121)
|
(134)
|
(131)
|
(202)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
1
|
3
|
4
|
7
|
10
|
12
|
14
|
15
|
18
|
20
|
22
|
23
|
24
|
26
|
27
|
28
|
30
|
30
|
30
|
29
|
27
|
|
| Other Non-Cash Items |
(0)
|
1
|
3
|
7
|
10
|
12
|
14
|
15
|
18
|
20
|
20
|
19
|
17
|
16
|
17
|
18
|
19
|
21
|
16
|
17
|
15
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
32
|
32
|
25
|
46
|
23
|
23
|
25
|
15
|
7
|
7
|
9
|
5
|
4
|
4
|
6
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
2
|
1
|
9
|
(1)
|
7
|
539
|
284
|
190
|
143
|
(424)
|
(229)
|
(145)
|
(103)
|
(72)
|
(9)
|
6
|
(26)
|
(18)
|
19
|
13
|
78
|
|
| Cash from Operating Activities |
(28)
N/A
|
(38)
-37%
|
(25)
+34%
|
(41)
-61%
|
(49)
-20%
|
567
N/A
|
513
-9%
|
504
-2%
|
492
-2%
|
(143)
N/A
|
(111)
+22%
|
(114)
-2%
|
(113)
+1%
|
(117)
-4%
|
(104)
+11%
|
(110)
-6%
|
(114)
-4%
|
(117)
-3%
|
(98)
+16%
|
(100)
-1%
|
(108)
-9%
|
|
| Investing Cash Flow | ||||||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(4)
|
(4)
|
(3)
|
(2)
|
(1)
|
(1)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(445)
|
(477)
|
(456)
|
(432)
|
76
|
39
|
35
|
(80)
|
(129)
|
(13)
|
57
|
|
| Cash from Investing Activities |
(0)
N/A
|
(1)
-25%
|
(0)
+20%
|
(1)
-25%
|
(1)
-60%
|
(1)
-63%
|
(1)
+8%
|
(1)
-17%
|
(2)
-7%
|
(1)
+33%
|
(446)
-44 510%
|
(478)
-7%
|
(457)
+4%
|
(434)
+5%
|
73
N/A
|
35
-52%
|
31
-11%
|
(83)
N/A
|
(131)
-58%
|
(14)
+89%
|
57
N/A
|
|
| Financing Cash Flow | ||||||||||||||||||||||
| Net Issuance of Common Stock |
148
|
362
|
339
|
215
|
215
|
1
|
3
|
3
|
3
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
123
|
123
|
123
|
123
|
5
|
|
| Other |
2
|
0
|
1
|
(1)
|
(0)
|
1
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
|
| Cash from Financing Activities |
149
N/A
|
362
+143%
|
340
-6%
|
213
-37%
|
215
+1%
|
2
-99%
|
4
+76%
|
3
-11%
|
3
+3%
|
3
-12%
|
2
-33%
|
2
+15%
|
2
-4%
|
2
N/A
|
1
-49%
|
1
-52%
|
123
+22 837%
|
122
0%
|
122
0%
|
122
+0%
|
4
-96%
|
|
| Change in Cash | ||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
1
|
2
|
1
|
1
|
(8)
|
(3)
|
(3)
|
(5)
|
(7)
|
(9)
|
(10)
|
(8)
|
1
|
(4)
|
(4)
|
(5)
|
(2)
|
(2)
|
1
|
4
|
|
| Net Change in Cash |
121
N/A
|
324
+168%
|
316
-2%
|
174
-45%
|
166
-4%
|
560
+237%
|
512
-8%
|
503
-2%
|
489
-3%
|
(147)
N/A
|
(564)
-282%
|
(599)
-6%
|
(576)
+4%
|
(548)
+5%
|
(34)
+94%
|
(79)
-134%
|
35
N/A
|
(80)
N/A
|
(109)
-36%
|
10
N/A
|
(43)
N/A
|
|
| Free Cash Flow | ||||||||||||||||||||||
| Free Cash Flow |
(28)
N/A
|
(38)
-37%
|
(26)
+33%
|
(41)
-60%
|
(50)
-21%
|
565
N/A
|
512
-9%
|
503
-2%
|
490
-2%
|
(144)
N/A
|
(112)
+22%
|
(115)
-2%
|
(114)
+1%
|
(119)
-4%
|
(107)
+10%
|
(113)
-6%
|
(118)
-4%
|
(120)
-2%
|
(100)
+17%
|
(100)
-1%
|
(109)
-8%
|
|